Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy

Inclusion Criteria:

   - Patients with gynecologic cancer who are undergoing vaginal brachytherapy as part of
   their treatment

   - Patients cannot have previously received pelvic external beam radiation or
   brachytherapy. Patients may be enrolled while undergoing vaginal brachytherapy
   radiation treatment.

   - Patients should have a life expectancy of at least 1 year

   - No Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status
   requirements

   - No organ and marrow function requirements

   - Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

   - Patients who have received prior pelvic external beam radiation or brachytherapy will
   be excluded

   - No restrictions regarding use of other investigational agents

   - No exclusion requirements due to co-morbid disease or intercurrent illness

   - No investigational agent, so no exclusion requirements regarding history of allergic
   reactions attributed to compounds of similar chemical or biologic composition to
   investigational agent or device

   - No exclusion criteria relating to concomitant medications

   - No exclusion criteria for pregnant or nursing patients from participating in this
   study (Of note, pregnant patients will not be treated with vaginal brachytherapy, a
   requirement for enrolling on this study)